Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Human Immune-Boosting Cancer Drugs Seen Extending Lives
Bloomberg
Monday, May 13, 2013 - 9:11am
tags:
cancer, Merck, Bristol-Myers Squibb, Roche
A Closer Look at GlaxoSmithKline's Dividend Potential
Motley Fool
Monday, May 13, 2013 - 9:08am
tags:
dividends, GSK
Sequenom Meets on the Top Line, Misses Where it Counts
Motley Fool
Sunday, May 12, 2013 - 11:14am
tags:
Sequenom
6 Big Pharma Stocks With Lower Credit Risk Than U.S. Treasuries: Part II
Motley Fool
Sunday, May 12, 2013 - 11:10am
tags:
Merck, Novartis, Pfizer
China Biotech In Review: Sagent Buys Out China JV Partner For $25 Million
Seeking Alpha
Sunday, May 12, 2013 - 11:09am
tags:
ScinoPharm, Sagent Pharmaceuticals, Huahai Pharma, Oncobiologics, Chi-Med, Beta Pharma, Amgen, Beijing Leadman Biochemistry
London-Based Hedgie Focusing On Big Pharma
Motley Fool
Sunday, May 12, 2013 - 11:04am
tags:
Pfizer, Merck, Eli Lilly
Pernix Therapeutics Reports First Quarter 2013 Financial Results
Enhanced Online News
Sunday, May 12, 2013 - 11:03am
tags:
Pernix, earnings
This Week in Biotech
Motley Fool
Sunday, May 12, 2013 - 11:02am
tags:
GSK, Theravance, Breo Ellipta, Pain Therapeutics, Durect, Pfizer, Remoxy, Eli Lilly, enzastaurin
Amgen, Zhejiang Beta Pharma form JV to commercialise Vectibix in Chinese market
Pharmabiz
Sunday, May 12, 2013 - 11:00am
tags:
Beta Pharma, Vectibix, Amgen, colorectal cancer
Dendreon: Picking Through the Carnage (video)
Motley Fool
Sunday, May 12, 2013 - 10:57am
tags:
Dendreon
Deal Discussions Distract From Disappointing Obesity Drug Sales (video)
Motley Fool
Sunday, May 12, 2013 - 10:55am
tags:
Arena Pharmaceuticals, Vivus, obesity, weight loss
BioSante Pharmaceuticals, Inc. Reports First Quarter Financial Results
Enhanced Online News
Saturday, May 11, 2013 - 11:52am
tags:
BioSante, earnings
Pacira Pharmaceuticals Reports Wider Loss
Zacks
Saturday, May 11, 2013 - 11:50am
tags:
Pacira, earnings
Should You Own Pfizer Stock?
Wall Street Cheat Street
Saturday, May 11, 2013 - 11:47am
tags:
Pfizer
Some Fish Oil Doesn't Help Some Patients in Some Countries
Motley Fool
Saturday, May 11, 2013 - 11:46am
tags:
fish oil
FDA allows generic forms of Endo Health's Opana ER painkiller
Reuters
Saturday, May 11, 2013 - 11:41am
tags:
Endo, Opana ER, Opana, pain management
Bristol-Myers Squibb Company: Today's Featured Health Care Winner
The Street
Saturday, May 11, 2013 - 11:40am
tags:
Bristol-Myers Squibb
Boston Scientific’s Mahoney Says Watchman Key to Growth
Bloomberg
Saturday, May 11, 2013 - 11:39am
tags:
Boston Scientific, WATCHMAN, atrial fibrillation, devices
Breo Ellipta gains US approval for the treatment of COPD
Yahoo/PR Newswire
Saturday, May 11, 2013 - 11:20am
tags:
Breo Ellipta, COPD, GSK, Theravance
Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Ventrus Biosciences, Inc.
Yahoo/PR Newswire
Saturday, May 11, 2013 - 11:18am
tags:
Ventrus, lawsuits

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.